TLR3 and breast cancer: Furthermore, RAW264.7 cells were treated with poly (1: C) HMW and imiquimod, agonist of TLR3 and TLR7, respectively, and also in this setting, PPP and BC significantly reduced the expression of IL6 and COX2 (Figures 5A, B).